Siddhartha Devarakonda

Swedish Medical Center — United States

Medicine · Health Sciences

20h-index2.9kcitations129works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(60), Cancer Genomics and Diagnostics(42), RNA modifications and cancer(34), Lung Cancer Research Studies(30), Epigenetics and DNA Methylation(23)

Publications128 total

Cancer care disparities among patients with limited English proficiency: challenges and strategies for equity
BJC Reports·2025· 1 citedOpen Access
648 A pilot study to evaluate the combination of zimberelimab, domvanalimab and etrumadenant in patients with previously treated non-small cell lung cancer (NSCLC)
Regular and Young Investigator Award Abstracts·2025Open Access
MA08.05 PALOMA-2: Subcutaneous Amivantamab Administered Every 4 Weeks Plus Lazertinib in First-Line EGFR-Mutated Advanced NSCLC
Journal of Thoracic Oncology·2025
1382P Vebreltinib efficacy and safety in NSCLC patients with METex14 skipping mutations
Annals of Oncology·2024Open Access
PP01.104 Vebreltinib Efficacy In METex14 Mutant NSCLC With or Without Concurrent MET Amplification, MET GCN Status Distributions Compared With Public Databases
Journal of Thoracic Oncology·2024· 1 citedOpen Access
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer
Journal of Thoracic Disease·2024· 5 citedOpen Access
Outcomes in Patients with Spinal Metastases Managed with Surgical Intervention
Cancers·2024· 17 citedOpen Access
P2.17-05 Characterizing Mechanisms of Treatment Resistance in SCLC
Journal of Thoracic Oncology·2023Open Access
P2.09-41 Phase I/II Study Exploring Safety and Efficacy of Apl-101 Plus Frontline Osimertinib in EGFR-mutated Metastatic Non-small Cell Lung Cancer
Journal of Thoracic Oncology·2023Open Access
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
npj Precision Oncology·2023· 24 citedOpen Access
Non-Small Cell Lung Cancer Epigenomes Exhibit Altered DNA Methylation in Smokers and Never-Smokers
Genomics Proteomics & Bioinformatics·2023· 14 citedOpen Access
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data
Clinical Lung Cancer·2023· 5 citedOpen Access
Supplementary Table from Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis
2023Open Access
Supplementary Figures from Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations
2023Open Access
Supplementary Table from Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis
2023Open Access
Supplementary Table from Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis
2023Open Access
Supplementary Table from Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis
2023Open Access
Supplementary Figure from Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis
2023Open Access
Data from Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations
2023Open Access
Supplementary Table from Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Ramaswamy Govindan(40), Daniel Morgensztern(21), Saiama N. Waqar(16), Brett H. Herzog(6), Ming‐Sound Tsao(5), Ashiq Masood(5), Clifford G. Robinson(5), Pamela Samson(4), Feng Gao(4), Varun Puri(4), Maria Q. Baggstrom(4), Mark A. Watson(4), Jeffrey P. Ward(4), Trudy G. Oliver(3), Frances A. Shepherd(3), Stephen L. Graziano(3), Robert A. Kratzke(3), Jean‐Charles Soria(3), Lesley Seymour(3), Stefan Michiels(3)